Furthermore, eIF2A promotes breast cancer cell survival during paclitaxel-mediated integrated stress response (18) and stimulates translation of CCNB1 mRNA leading to hepatocellular carcinoma progression (19). This evidence concerns the gene EIF2A and breast carcinoma.